Repurposing of the bisbenzimide antibiotic Ridinilazole as an antiviral compound against human cytomegalovirus. Pinto H, Latham KA, Goodbourn S, Witney AA, et al. J Gen Virol 2025;106.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pinto H, Latham KA, Goodbourn S, Witney AA, et al. Repurposing of the bisbenzimide antibiotic Ridinilazole as an antiviral compound against human cytomegalovirus. J Gen Virol 2025;106.
PMID: 41417496